318 related articles for article (PubMed ID: 26844272)
21. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
22. Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development.
Cantù C; Zimmerli D; Hausmann G; Valenta T; Moor A; Aguet M; Basler K
Genes Dev; 2014 Sep; 28(17):1879-84. PubMed ID: 25184676
[TBL] [Abstract][Full Text] [Related]
23. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
[TBL] [Abstract][Full Text] [Related]
24. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
Fodde R; Brabletz T
Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.
Riemer P; Rydenfelt M; Marks M; van Eunen K; Thedieck K; Herrmann BG; Blüthgen N; Sers C; Morkel M
J Cell Biol; 2017 Jun; 216(6):1567-1577. PubMed ID: 28442534
[TBL] [Abstract][Full Text] [Related]
26. A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer.
Tanton H; Sewastianik T; Seo HS; Remillard D; Pierre RS; Bala P; Aitymbayev D; Dennis P; Adler K; Geffken E; Yeoh Z; Vangos N; Garbicz F; Scott D; Sethi N; Bradner J; Dhe-Paganon S; Carrasco RD
Sci Adv; 2022 Apr; 8(17):eabm3108. PubMed ID: 35486727
[TBL] [Abstract][Full Text] [Related]
27. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
[TBL] [Abstract][Full Text] [Related]
28. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
[TBL] [Abstract][Full Text] [Related]
29. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
30. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
[TBL] [Abstract][Full Text] [Related]
31. Targeting CDK12 obviates the malignant phenotypes of colorectal cancer through the Wnt/β-catenin signaling pathway.
Liu S; Wu J; Lu X; Guo C; Zheng Q; Wang Y; Hu Q; Bian S; Luo L; Cheng Q; Liu Z; Dai W
Exp Cell Res; 2023 Jul; 428(1):113613. PubMed ID: 37100369
[TBL] [Abstract][Full Text] [Related]
32. BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins.
Jiang M; Kang Y; Sewastianik T; Wang J; Tanton H; Alder K; Dennis P; Xin Y; Wang Z; Liu R; Zhang M; Huang Y; Loda M; Srivastava A; Chen R; Liu M; Carrasco RD
Nat Commun; 2020 Jan; 11(1):19. PubMed ID: 31911584
[TBL] [Abstract][Full Text] [Related]
33. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
34. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration.
Brack AS; Murphy-Seiler F; Hanifi J; Deka J; Eyckerman S; Keller C; Aguet M; Rando TA
Dev Biol; 2009 Nov; 335(1):93-105. PubMed ID: 19699733
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
[TBL] [Abstract][Full Text] [Related]
36. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
37. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
[TBL] [Abstract][Full Text] [Related]
38. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M
Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710
[TBL] [Abstract][Full Text] [Related]
39. The Intestinal Wnt/TCF Signature.
Van der Flier LG; Sabates-Bellver J; Oving I; Haegebarth A; De Palo M; Anti M; Van Gijn ME; Suijkerbuijk S; Van de Wetering M; Marra G; Clevers H
Gastroenterology; 2007 Feb; 132(2):628-32. PubMed ID: 17320548
[TBL] [Abstract][Full Text] [Related]
40. Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.
Deka J; Wiedemann N; Anderle P; Murphy-Seiler F; Bultinck J; Eyckerman S; Stehle JC; André S; Vilain N; Zilian O; Robine S; Delorenzi M; Basler K; Aguet M
Cancer Res; 2010 Aug; 70(16):6619-28. PubMed ID: 20682801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
